Stay updated on Lirentelimab in Eosinophilic Esophagitis Clinical Trial

Sign up to get notified when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T16:52:05.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding/operating status notice as well as the prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T03:01:24.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding notice banner was added and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T01:21:09.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI changes include showing the glossary, adding labels like 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updating the revision tag to v3.4.0.
    Difference
    0.1%
    Check dated 2026-01-27T23:57:36.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was introduced; there are no visible user-facing changes to the Study Details page beyond the version label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-13T19:13:31.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing all study sites by state and country. Removed the individual state location subsections (e.g., Alabama Locations) and the HHS Vulnerability Disclosure link.
    Difference
    2%
    Check dated 2025-12-23T08:09:32.000Z thumbnail image

Stay in the know with updates to Lirentelimab in Eosinophilic Esophagitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.